Text to speech

A Vaccine for Alzheimer’s? Antibody Clears Brain Plaques in Mice

By | April 3rd, 2018

Most scientists believe that Alzheimer’s is caused by a build-up of beta-amyloid, a sticky protein, in the brain. Whether this is because the brain produces too much or because it loses the ability to clear the plaque, scientists are still trying to suss out. One thing is for sure: When the brain has too much beta-amyloid, it forms into plaques that cause neuron death, which leads to the breakdown of memory and communication between parts of the brain.

Scientists at Washington University School of Medicine may have found a weapon to fight against this build-up. They developed an antibody that was able to clear the plaques in mice that were genetically engineered to develop Alzheimer’s. Study authors hope the findings will light the way to a treatment that could clear the plaques before the symptoms have a chance to develop.

“Many people build up amyloid over many years, and the brain just can’t get rid of it,” said senior author David Holtzman, MD, head of the Department of Neurology. “By removing plaques, if we start early enough, we may be able to stop the changes to the brain that result in forgetfulness, confusion and cognitive decline.”

Scientists now know that beta-amyloid starts to build up decades before Alzheimer’s symptoms start to show, up to 30 years before a diagnosis is likely. There’s still no effective treatment for Alzheimer’s, but most researchers now agree that in order to stop it in its tracks, it needs to be treated much earlier, before patients are symptomatic.

One way to get rid of the plaques is to target them with antibodies, but past studies have shown that doing so can trigger inflammation, which is also tied to Alzheimer’s. Instead, the Washington University researchers targeted a protein called ApoE, which is bundled inside of the plaques. Most humans have one of three variants of ApoE, and certain variants are considered the single most telling factor in whether a person will develop Alzheimer’s. When the antibody binds with ApoE, it attracts immune cells, which destroy it.

In the experiment on mice, when the ApoE was destroyed, the plaques were destroyed along with it. Mice who were injected with the antibody, called HAE-4, had 50 percent fewer plaques than they did before they were injected.

What’s more, this antibody targeted only ApoE in the brain, even though it also exists in the blood. Because ApoE transports fats in the bloodstream, removing it could be dangerous.

“It turns out that the APOE in the plaques has a different structure than the form of APOE found in the blood,” Holtzman said. “The HAE-4 antibody recognized only the form found attached to the plaques in the brain.”

Next, the researchers plan to prepare the antibody for trials in humans.

This study was published in The Journal of Clinical Investigation.

If you find our articles and interviews helpful, please consider becoming a supporting member of our community. Frustrated by the lack of an editorially independent source of information on brain health and Alzheimer’s disease, we decided to create Being Patient. We are a team of dedicated journalists covering the latest research on Alzheimer’s, bringing you access to the experts and elevating the patient perspective on what it’s like to live with dementia.

Please help support our mission.

18 thoughts on “A Vaccine for Alzheimer’s? Antibody Clears Brain Plaques in Mice

  1. This sounds wonderful! I would love to be considered in this trial study! How do I apply for the study? I am seriously wanting to do this!

  2. My mother passed from Alzheimer’s and my Aunt from Parkinson’s. I am very interested in any research. Please respond. I am 72 female. Live near Duke in NC.

  3. Is there a chance this could also be applied to cerebral amyloid angiopathy? So little is known about it….

  4. Wow this is interesting. I would be interested to learn more and if there are human trials my husband would be interested. He has been recently diagnosed with early on set.

  5. I am interested in information regarding any trials. I am located in the Phoenix, AZ metro area. Candyce Henry

  6. My husband was diagnosed with Alzheimer’s. Where are these trials taking place. We would be very interested. He had just completed chemo, immunotherapy, and radiation for cancer(which is now not evident in the lung) when diagnosed with dementia.

  7. I’m interested for my wife Mary. Mary has been involved in two different study’s for AD neither of which produced positive results. Mary’s AD has moved to moderate over the past year and we are afraid of the future. Mary is 65 and a retired teacher. We live in suburban Chicago.

Leave a Reply

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.